Bright Minds Biosciences (DRUG) Retained Earnings (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Retained Earnings of $5.4 million for Q1 2026, up 12.46% on a QoQ basis from $4.8 million in Q4 2025, and up 148.51% year-over-year from $2.2 million in Q1 2025.
Bright Minds Biosciences (DRUG) Retained Earnings (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Retained Earnings history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- Quarterly Retained Earnings rose 148.51% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 148.51% YoY) and the FY2025 annual result came in at $3.9 million, up 32.95% from the prior year.
- Retained Earnings was $5.4 million for Q1 2026 at Bright Minds Biosciences, up from $4.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $5.4 million in Q1 2026 and bottomed at -$23.5 million in Q3 2023.
- A 5-year average of $1.2 million and a median of $2.2 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings tumbled 1337.79% — and 2026, when it soared 148.51%.
- Bright Minds Biosciences' Retained Earnings stood at $2.2 million in 2022, then grew by 13.9% to $2.5 million in 2023, then slipped by 10.57% to $2.2 million in 2024, then surged by 114.49% to $4.8 million in 2025, then advanced by 12.46% to $5.4 million in 2026.
- Business Quant data shows DRUG's Retained Earnings at $5.4 million in Q1 2026, $4.8 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 5.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 2.16 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | -23.53 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.46 Mn |
| Sep 30, 2021 | -7.32 Mn |
| Jun 30, 2021 | 992,055.69 |